COMPANY   |   TECHNOLOGY   |   PRODUCTS   |   NEWS   |   CAREERS   |   CONTACT   |   ORDER INQUIRY   |   INVESTORS

The Power to Change Lives

When you need to identify


a patient's bacterial infection and the proper treatment, you cannot afford to wait days for results. Time is critical. You need rapid answers. Because knowledge is power – the power to save lives.

MicroPhage offers

the solutions you demand – the easy-to-use, rapid diagnostics that provide the information necessary to effectively treat your patients.

The MicroPhage MRSA/MSSA Blood Culture Test empowers better treatment decisions by identifying and determining
methicillin resistance or susceptibility of S. aureus. » more

MicroPhage news: MicroPhage CEO Alene A. Campbell receives recognition as a "Remarkable Woman" by the
Boulder County Business Report. » more

With the MicroPhage MRSA/MSSA Screening Test clinicians can quickly and affordably screen patients for
methicillin-resistant and methicillin-susceptible S. aureus. » more

All contents © 2003-2010 MicroPhage, Inc.